Search clinical trials for: Therapeutic Anticoagulation

Total 13037 results

Anthos Therapeutics, Inc.

Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) (LILAC-TIMI 76)

Atrial Fibrillation (AF)

United States, Canada, Israel, Japan, China, Brazil, Chile, United Kingdom, Bulgaria, Germany, Hungary, Italy, Poland, Romania, Spain, Czechia, Latvia, Mexico
University Hospital, Tours

Not yet recruiting

Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients (CARD-AXA)

Chronic Hemodialysis Patients
Shanghai Zhongshan Hospital

Recruiting

Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis

Venous Thrombosis

China
Cairo University

Recruiting

Early Versus Late Post Caesarean Section Oral Anticoagulation Initiation and Risk of Maternal Complications in Patients With Mechanical Heart Valve Prosthesis

Maternal Complications After Oral Anticoagulation When Initiated Early and Late After Caesarean Section Done for Patients With Mechanical Heart Valve Prosthesis

Egypt
Massachusetts General Hospital
Bristol-Myers Squibb

Recruiting

Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19

Cardiovascular Diseases | COVID-19

United States
UMC Utrecht
National University Hospital, Singapore; Berry Consultants; University of Pittsburgh... and other collaborators

Recruiting

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia (REMAP-CAP)

Community-acquired Pneumonia, Influenza, COVID-19

United Kingdom, United States, Canada, Australia, Netherlands, Croatia, Germany, Belgium, New Zealand, Ireland, Spain, Japan, Hungary, Colombia, India, Nepal, Pakistan, Portugal, Romania, Saudi Arabia
Matthew Neal MD
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE (ACTIV-4A)

Covid19

United States, Spain, Brazil, Italy
Anthos Therapeutics, Inc.
Laboratory Corporation of America; The TIMI Study Group

Active, not recruiting

Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation (AZALEA-TIMI 71)

Stroke | Atrial Fibrillation (AF)

United States, Canada, Czechia, Hungary, Korea, Republic of, Poland, Taiwan
JDP Therapeutics, Inc.

Completed

Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria

Acute Urticaria

Canada, United States
Assistance Publique - Hôpitaux de Paris
LEO Pharma

Completed

Therapeutic Anticoagulation Strategy for Acute Chest Syndrome (TASC)

Anemia | Acute Chest Syndrome | Sickle Cell | Low-Molecular-Weight Heparin

France
University of Alabama at Birmingham

Completed

Evaluation of Complication Rates Using Filter vs. Centrifuge and Heparin vs. Citrate Anticoagulation

Therapeutic Plasma Exchange | Anticoagulant Therapy

United States
Ministry of Health, Spain
Sociedad Española de Neumología y Cirugía Torácica; American College of Chest...

Completed

Pulmonary Embolism as a Cause of COPD Exacerbations (SLICE)

Chronic Obstructive Pulmonary Disease | Pulmonary Embolism

Spain
Assistance Publique - Hôpitaux de Paris

Completed

ANTIcoagulation in Severe COVID-19 Patients (ANTICOVID)

Severe COVID-19 Pneumonia

France
PharmaDiall Ltd.

Active, not recruiting

A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement

Venous Thromboembolism

Russian Federation
Charite University, Berlin, Germany
Bayer; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

Terminated

Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19 (COVID-PREVENT)

COVID-19

Germany
PharmaDiall Ltd.

Completed

Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19

COVID-19 | Venous Thromboembolism

Russian Federation
PharmaDiall Ltd.

Completed

A Study of Pharmacokinetics, Safety and Tolerability of Dimolegin (DD217)

Healthy Volunteers

Russian Federation
University of Sao Paulo General Hospital
Unity Health Toronto; University of Vermont Medical Center

Completed

A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic (RAPID-BRAZIL)

Severe Acute Respiratory Syndrome | Coronavirus Infection | COVID | Anticoagulants and Bleeding Disorders | Thromboembolism, Venous

Brazil
Unity Health Toronto
University of Alberta; University of Sao Paulo; The Ottawa Hospital; Maisonneuve-Rosemont... and other collaborators

Completed

Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care

COVID-19

Canada
William Beaumont Hospitals

Completed

Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units

Covid19

United States
Benha University

Completed

Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic

Covid19

Egypt
Changhai Hospital
Wuhan University; Qilu Hospital of Shandong University; The First Affiliated... and other collaborators

Unknown

Efficacy and Safety of Bivalirudin Versus Heparin During Coil Embolization in Patients With Ruptured Intracranial Aneurysms (BUILD)

Subarachnoid Hemorrhage, Aneurysmal
Celgene

Completed

A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

Carcinoma, Non-Small-Cell Lung | Urinary Bladder Neoplasms | Tumor Virus Infections | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Carcinoma, Transitional Cell | Carcinoma, Pancreatic Ductal

Spain, United States, France, Netherlands
Wuhan Asia Heart Hospital

Unknown

AI-based Social Software to Manage wARfarin Therapy (AI-SMART)

Anticoagulant-induced Bleeding | Warfarin Sodium Causing Adverse Effects in Therapeutic Use

China
University Medical Centre Ljubljana

Unknown

Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation

Guillain-Barre Syndrome | Humoral Rejection | CIDP | Miller Fisher Syndrome | Good Pasture Syndrome | Hyperviscosity Syndrome

Slovenia
Johannes Gutenberg University Mainz
Sanofi; Bayer; Boehringer Ingelheim; German Federal Ministry of Education and Research and other collaborators

Completed

Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme (thrombEVAL)

Atrial Fibrillation | Venous Thromboembolism | Anticoagulant Antagonists, Vitamin K and Other Coagulants Causing Adverse Effects in Therapeutic Use

Germany
University Hospital, Montpellier

Completed

Evaluation of the Contribution of a Pre-consultation Questionnaire on the Therapeutic Education (EDUCONSULT)

Under Oral Anticoagulation Patients

France
University of Alberta
Vancouver Coastal Health Research Institute

Completed

The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT

Atrial Fibrillation | Thromboembolism | Deep Venous Thrombosis | DVT | Thrombus Due to Heart Valve Prosthesis

Canada
University of Alberta

Completed

Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial

Anticoagulation

Canada
Mayo Clinic
LivaNova

Completed

Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual Care

Management of Anticoagulation

United States
University of Calgary
LEO Pharma

Completed

Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing

Venous Thromboembolism

Canada
ARYx Therapeutics

Unknown

Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation (EmbraceAC)

Myocardial Infarction | Atrial Fibrillation | Atrial Flutter | Cardiomyopathy | Venous Thromboembolic Disease

United States
University of Pittsburgh
GlaxoSmithKline

Completed

Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers

Venous Thrombosis | Pulmonary Embolism

United States
ARYx Therapeutics

Completed

Study of a New Anticoagulant Drug in Patients With Atrial Fibrillation

Atrial Fibrillation

United States
Boston Immune Technologies and Therapeutics

Not yet recruiting

A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System

Peripheral T-cell Lymphoma | NHL | Cutaneous T Cell Lymphoma
Northern Jiangsu People's Hospital

Recruiting

Comparative Analysis of Short-Term Therapeutic Effects Between the π-Shaped and Overlap Methods for Esophagogastrostomy in Totally Laparoscopic Total Gastrectomy

Gastric Cancer

China
Kyverna Therapeutics

Not yet recruiting

A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis

Multiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive
MediLink Therapeutics (Suzhou) Co., Ltd.
Hoffmann-La Roche

Not yet recruiting

A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
University of Barcelona
Nou Barris Mental Health Center; Badalona Serveis Assistencials

Not yet recruiting

Identity-Based Transdiagnostic Therapy for Young People With Anxiety and Depression (IBTTYOUNG)

Depression | Anxiety

Spain
Viridian Therapeutics, Inc.

Not yet recruiting

A Randomized, Active Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

Thyroid Eye Disease

United States
Fresenius Medical Care Deutschland GmbH
KLIFO GmbH

Not yet recruiting

Clinical Performance of the New Plasma Filter PX2 in TPE Treatments (plasmaFlux)

Autoimmune Diseases

Germany
MedSIR
Stemline Therapeutics, Inc.

Not yet recruiting

Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i. (ADELA)

Advanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | ESR1 Gene Mutation
Acerand Therapeutics (Shanghai) Limited

Recruiting

Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors

Breast Cancer | Ovarian Cancer | Prostate Cancer | BRCA1 Mutation | BRCA2 Mutation | Solid Tumor, Adult

China
International Food Policy Research Institute
UNICEF; Ethiopian Public Health Association

Not yet recruiting

Increasing the Coverage of Severe Acute Malnutrition (SAM) Treatment in Ethiopia (R-SWITCH)

Wasting | Malnutrition, Child | Acute Malnutrition, Severe
Cullinan Therapeutics Inc.

Not yet recruiting

A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma

Multiple Myeloma
Resolution Therapeutics Limited

Recruiting

Study in Patients With Decompensated Liver Cirrhosis (OPAL)

Liver Cirrhosis

United Kingdom
Regeneron Pharmaceuticals
Intellia Therapeutics

Not yet recruiting

A Trial to Learn if REGV131-LNP1265 is Safe and Works to Help the Body Make Clotting Factor in Pediatric, Adolescent and Adult Patients With Hemophilia B (BEYOND-9)

Hemophilia B
Far Eastern Memorial Hospital

Not yet recruiting

Effect of Dialysis-specific Therapeutic Diet on Biochemical Parameters in Dialysis Patients

End-Stage Kidney Disease
Verismo Therapeutics

Recruiting

Long-Term Follow-Up Safety Study of Subjects Treated With SynKIR-110 in Cancer Studies

Cancer

United States
Nanfang Hospital, Southern Medical University

Not yet recruiting

To Optimize Therapeutic Procedures of DPMAS in ACLF Patients: a Prospective, Sigle Arm and Multicenter Study

Acute-On-Chronic Liver Failure

Search clinical trials for: Therapeutic Anticoagulation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations